Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2016 December;58(4) > Panminerva Medica 2016 December;58(4): 349-50

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Panminerva Medica 2016 December;58(4): 349-50

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Extension of the stability of anticancer drugs in pharmaceutical practice

Francesca BARATTA 1, Franca GOFFREDO 2, Laura ANNARATONE 3, Anna SAPINO 3, Oscar BERTETTO 4, Paola BRUSA 1

1 Department of Science and Pharmaceutical Technology, University of Turin, Turin, Italy; 2 Oncology Foundation of Piedmont Region, Institute for Cancer Research and Treatment (IRCC), Candiolo, Turin, Italy; 3 Department of Medical Sciences, University of Turin, Turin, Italy; 4 Interaziendale Interregionale Rete Oncologica Piemonte e Valle d’Aosta Department, A.O.U. Città della Salute e della Scienza, Turin, Italy


PDF


top of page